(Q34718201)

4 August 2017

1 reference

title

Chemoprevention: an essential approach to controlling cancer (English)

1 reference

4 August 2017

Michael B Sporn

1

1 reference

4 August 2017

Nanjoo Suh

series ordinal

2

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

4 August 2017

published in

Nature Reviews Cancer

1 reference

4 August 2017

volume

2

1 reference

4 August 2017

issue

7

1 reference

4 August 2017

page(s)

537-543

1 reference

https://scigraph.springernature.com/pub.10.1038/nrc844

4 August 2017

exact match

0 references

cites work

Signal Transduction and the Control of Gene Expression

1 reference

Alterations in DNA Methylation: A Fundamental Aspect of Neoplasia

31 March 2020

1 reference

DNA methylation: past, present and future directions

31 March 2020

1 reference

Histone deacetylases and cancer: causes and therapies

31 March 2020

1 reference

The nature of cancer: morphogenesis and progressive (self)-disorganization in neoplastic development and progression

31 March 2020

1 reference

Putting tumours in context

31 March 2020

1 reference

The microenvironment of the tumour-host interface

31 March 2020

1 reference

Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease

31 March 2020

1 reference

Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease

31 March 2020

1 reference

The nuclear receptor superfamily: the second decade

31 March 2020

1 reference

Biomedicine. Defining the "S" in SERMs

31 March 2020

1 reference

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

31 March 2020

1 reference

Prospects for prevention and treatment of cancer with selective PPARgamma modulators (SPARMs).

31 March 2020

1 reference

Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation

31 March 2020

1 reference

Nuclear receptors and lipid physiology: opening the X-files

31 March 2020

1 reference

Current understanding of the molecular actions of vitamin D.

31 March 2020

1 reference

Cancer chemoprevention using natural vitamin D and synthetic analogs

31 March 2020

1 reference

Vitamin D receptor as an intestinal bile acid sensor

31 March 2020

1 reference

Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators

31 March 2020

1 reference

Protein dynamics: implications for nuclear architecture and gene expression.

31 March 2020

1 reference

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

31 March 2020

1 reference

Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.

31 March 2020

1 reference

Nuclear factor-kappa B and cancer: its role in prevention and therapy

31 March 2020

1 reference

Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer

31 March 2020

1 reference

5-Aza-2'-deoxycytidine is chemopreventive in a 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone-induced primary mouse lung tumor model

31 March 2020

1 reference

Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer.

31 March 2020

1 reference

Transforming growth factor-beta1 is a new form of tumor suppressor with true haploid insufficiency.

31 March 2020

1 reference

TGFbeta signaling in growth control, cancer, and heritable disorders

31 March 2020

1 reference

Role of transforming growth factor-beta signaling in cancer

31 March 2020

1 reference

TGF-beta signaling in tumor suppression and cancer progression

31 March 2020

1 reference

Molecular mechanisms of inactivation of TGF-beta receptors during carcinogenesis

31 March 2020

1 reference

TGF-beta/Smad signaling defects in inflammatory bowel disease: mechanisms and possible novel therapies for chronic inflammation

31 March 2020

1 reference

Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease

31 March 2020

1 reference

The EGF/ErbB receptor family and apoptosis

31 March 2020

1 reference

ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, alone and in combination with radiation and chemotherapy as a new therapeutic strategy in non-small cell lung cancer

31 March 2020

1 reference

NF-kappaB in cancer: from innocent bystander to major culprit

31 March 2020

1 reference

The role of STATs in transcriptional control and their impact on cellular function

31 March 2020

1 reference

STAT proteins: novel molecular targets for cancer drug discovery

31 March 2020

1 reference

To cycle or not to cycle: a critical decision in cancer.

31 March 2020

1 reference

Hobson's choice and the need for combinations of new agents for the prevention and treatment of breast cancer

31 March 2020

1 reference

Glucocorticoid receptor inhibits transforming growth factor-beta signaling by directly targeting the transcriptional activation function of Smad3

31 March 2020

1 reference

Cross-talk between transforming growth factor-beta and estrogen receptor signaling through Smad3.

31 March 2020

1 reference

The androgen receptor represses transforming growth factor-beta signaling through interaction with Smad3.

31 March 2020

1 reference

From transforming growth factor-beta signaling to androgen action: identification of Smad3 as an androgen receptor coregulator in prostate cancer cells

31 March 2020

1 reference

Peroxisome proliferator-activated receptor gamma inhibits transforming growth factor beta-induced connective tissue growth factor expression in human aortic smooth muscle cells by interfering with Smad3

31 March 2020

1 reference

Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway.

31 March 2020

1 reference

31 March 2020

Cancer statistics, 2002

1 reference

Teratocarcinomas and other neoplasms as developmental defects in gene expression.

31 March 2020

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NRC844

1 reference

Dimensions Publication ID

4 August 2017

1004505196

0 references

1 reference